[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:pituitary-neuroendocrine-tumor":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":79,"states":80},"Pituitary Neuroendocrine Tumor",11,10,[8,16,22,28,35,42,48,54,60,66,72],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT03014687","Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions",[12],"Phase 4","RECRUITING","2026-08-26T02:18:13.438956Z","2026-05-05T02:43:26.984935Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT04278118","Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study",[],"2026-08-26T02:16:31.714843Z","2026-05-05T02:43:29.156766Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT04569591","DDAVP for Pituitary Adenoma",[],"2026-08-26T02:15:02.712396Z","2026-05-05T02:43:29.042409Z",{"nct_id":29,"title":30,"phases":31,"status":13,"updated_at":33,"content_modified":34},"NCT07460232","FET PET\u002FCT Imaging To Localize Pituitary Adenomas In Cushing Disease",[32],"Early Phase 1","2026-08-26T02:15:23.202838Z","2026-05-05T02:43:28.474511Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":40,"content_modified":41},"NCT07456878","Use of [18F] Fluoroethyl-L-tyrosine PET\u002FMRI for Identifying Small Functional Pituitary Adenomas",[39],"Phase 1","2026-08-26T02:18:17.950264Z","2026-05-05T02:43:28.345886Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":46,"content_modified":47},"NCT04081701","68-Ga DOTATATE PET\u002FMRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.",[12],"2026-08-26T02:15:09.079045Z","2026-05-05T02:43:27.179150Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":52,"content_modified":53},"NCT07335315","Evaluation of Intraoperative Contrast Enhanced Ultrasound for the Identification of Pituitary Adenoma in Cushing's Disease Compared to Other Pituitary Tumors",[],"2026-08-26T02:18:55.570428Z","2026-05-13T02:55:06.687919Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":58,"content_modified":59},"NCT02146170","Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors",[],"2026-08-26T02:18:24.494016Z","2026-05-13T02:55:06.091262Z",{"nct_id":61,"title":62,"phases":63,"status":13,"updated_at":64,"content_modified":65},"NCT00060541","Evaluation and Treatment of Neurosurgical Disorders",[],"2026-08-26T02:18:47.742071Z","2026-05-13T02:55:06.030447Z",{"nct_id":67,"title":68,"phases":69,"status":13,"updated_at":70,"content_modified":71},"NCT07493447","Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures",[32],"2026-08-26T02:18:38.077159Z","2026-07-05T03:45:20.252798Z",{"nct_id":73,"title":74,"phases":75,"status":76,"updated_at":77,"content_modified":78},"NCT06501716","ICG Angiogram as a Predictor of Postoperative Visual Function After EEA Surgery",[],"UNKNOWN","2026-08-03T02:45:04.257287Z","2026-05-13T02:55:06.495329Z",[],[81],{"state":82,"count":83,"slug":84},"Maryland",3,"maryland"]